Zhejiang Huakang Pharmaceutical Co., Ltd. — Investor Relations & Filings
About Zhejiang Huakang Pharmaceutical Co., Ltd.
Zhejiang Huakang Pharmaceutical Co., Ltd. specializes in the research, development, and large-scale production of functional sugar alcohols. Its core product range includes xylitol, sorbitol, maltitol, erythritol, and xylose. These ingredients are primarily utilized as high-quality sugar substitutes and functional additives within the food, beverage, and personal care sectors. The company employs advanced hydrogenation and separation technologies to ensure high purity and consistency across its product lines. Huakang serves a global market, providing essential raw materials for the formulation of sugar-free and low-calorie consumer goods. The organization maintains a focus on technological innovation and quality management systems to meet international standards for safety and efficacy in ingredient manufacturing.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 独立董事候选人声明与承诺(徐建妙) | 2026-04-23 | Chinese | |
| 华康股份关于董事会审计委员会对公司2025年审计机构履行监督职责情况的报告 | 2026-04-23 | Chinese | |
| 华康股份可转债转股结果暨股份变动公告 | 2026-04-01 | Chinese | |
| 华康股份关于为全资子公司提供担保额度的进展公告 | 2026-03-11 | Chinese | |
| 华康股份关于注销向不特定对象发行可转换公司债券募集资金专项账户的公告 | 2026-02-10 | Chinese | |
| 华康股份关于持股5%以上股东减持公司可转换公司债券暨权益变动的提示性公告 | 2026-01-23 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
12 filings
| |||||
| 39188387 | 独立董事候选人声明与承诺(徐建妙) | 2026-04-23 | Chinese | ||
| 39188380 | 华康股份关于董事会审计委员会对公司2025年审计机构履行监督职责情况的报告 | 2026-04-23 | Chinese | ||
| 39188372 | 华康股份可转债转股结果暨股份变动公告 | 2026-04-01 | Chinese | ||
| 39188370 | 华康股份关于为全资子公司提供担保额度的进展公告 | 2026-03-11 | Chinese | ||
| 39188361 | 华康股份关于注销向不特定对象发行可转换公司债券募集资金专项账户的公告 | 2026-02-10 | Chinese | ||
| 39188352 | 华康股份关于持股5%以上股东减持公司可转换公司债券暨权益变动的提示性公告 | 2026-01-23 | Chinese | ||
| 39188345 | 华康股份关于部分控股股东及其一致行动人股票质押式回购交易提前购回的公告 | 2026-01-09 | Chinese | ||
| 39188336 | 华康股份关于实际控制人及其一致行动人减持可转换公司债券暨权益变动的提示性公告 | 2026-01-09 | Chinese | ||
| 39188327 | 华康股份关于持股5%以上股东股票质押式回购交易提前购回的公告 | 2026-01-09 | Chinese | ||
| 39188318 | 华康股份可转债转股结果暨股份变动公告 | 2026-01-05 | Chinese | ||
| 39188311 | 华康股份关于为全资子公司提供担保额度的进展公告 | 2026-01-05 | Chinese | ||
| 39188305 | 华康股份关于实际控制人及其一致行动人减持可转换公司债券暨权益变动的提示性公告 | 2026-01-05 | Chinese | ||
|
2025
3 filings
| |||||
| 39188297 | 华康股份关于部分控股股东及其一致行动人进行质押式回购交易展期的公告 | 2025-12-31 | Chinese | ||
| 39188291 | 华康股份关于持股5%以上股东进行质押式回购交易展期的公告 | 2025-12-31 | Chinese | ||
| 39188283 | 华康股份关于实际控制人及其一致行动人减持可转换公司债券暨权益变动的提示性公告 | 2025-12-26 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of starches and starch products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Archer-Daniels-Midland Co
A global agricultural supply chain manager and processor of…
|
ADM | US | Manufacturing |
|
Asia Bio-Chem Group Corp.
Manufacturer and supplier of corn-based products and deriva…
|
ABC | CA | Manufacturing |
|
BAOLINGBAO BIOLOGY CO.,LTD.
Produces functional sugar products, prebiotics, and dietary…
|
002286 | CN | Manufacturing |
|
China Starch Holdings Limited
Manufacture and sale of corn-refined products, including co…
|
3838 | HK | Manufacturing |
|
Copam
Producer of starch and derivatives from corn for food and i…
|
CPA | PT | Manufacturing |
|
DAESANG HOLDINGS CO., LTD
A food and biotech holding company with food and industrial…
|
084690 | KR | Manufacturing |
|
Gayatri BioOrganics Ltd
Produces starch and derivatives for food, pharma, and indus…
|
524564 | IN | Manufacturing |
|
Global Corn Group Limited
A leading PRC producer of corn sweeteners and refined produ…
|
3889 | HK | Manufacturing |
|
Gujarat Ambuja Exports Ltd.
Agro-processor specializing in corn starch derivatives, soy…
|
GAEL | IN | Manufacturing |
|
Ingredion Inc
Transforms plant-based materials into value-added ingredien…
|
INGR | US | Manufacturing |
Zhejiang Huakang Pharmaceutical Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57968/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57968 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57968 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57968 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57968}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zhejiang Huakang Pharmaceutical Co., Ltd. (id: 57968)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.